Taken together, we found that T and B cells synergy increased after NAPC, and that CD4+ T cells may collaborate with B cells to promote CD8+ T cells phenotypic changes to CD127+ and KLRG1+ CD8 T cells, indicating that these subsets may be central elements by which PD-1 blockade enhanced anti-tumor immunity. Here, PDCD1 is linked to neoplasm.